Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeLorenzo Gerratana, Grazia Arpino, Debora Basile et al.|Cancer Treatment Reviews|2018Cited by 282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Maria Rosa Cappelletti et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Fabio Puglisi, Lorenzo Gerratana et al.|Cancer Treatment Reviews|2019Cited by 124
Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast CancerNurmaa K. Dashzeveg, Huiping Liu, Yuzhi Jia et al.|Cancer Discovery|2023Cited by 57
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giampaolo Bianchini, Giulia Viale et al.|npj Breast Cancer|2023Cited by 18